A detailed history of Srs Capital Advisors, Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 17,818 shares of TECH stock, worth $1.39 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
17,818
Previous 15,444 15.37%
Holding current value
$1.39 Million
Previous $1.09 Million 17.39%
% of portfolio
0.13%
Previous 0.12%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$62.12 - $84.15 $147,472 - $199,772
2,374 Added 15.37%
17,818 $1.28 Million
Q1 2024

May 14, 2024

BUY
$65.98 - $77.09 $36,354 - $42,476
551 Added 3.7%
15,444 $1.09 Million
Q4 2023

Feb 06, 2024

BUY
$52.83 - $78.22 $41,524 - $61,480
786 Added 5.57%
14,893 $1.15 Million
Q3 2023

Nov 14, 2023

BUY
$67.52 - $89.42 $632,527 - $837,686
9,368 Added 197.68%
14,107 $960,000
Q2 2023

Aug 14, 2023

BUY
$73.76 - $85.98 $45,509 - $53,049
617 Added 14.97%
4,739 $386,000
Q1 2023

May 16, 2023

BUY
$71.62 - $86.62 $9,668 - $11,693
135 Added 3.39%
4,122 $305,000
Q4 2022

Feb 24, 2023

BUY
$80.67 - $352.29 $242,332 - $1.06 Million
3,004 Added 305.6%
3,987 $330,000
Q3 2022

Nov 03, 2022

SELL
$282.54 - $391.85 $8,193 - $11,363
-29 Reduced 2.87%
983 $279,000
Q2 2022

Aug 22, 2022

BUY
$322.67 - $449.65 $18,714 - $26,079
58 Added 6.08%
1,012 $351,000
Q1 2022

May 12, 2022

BUY
$353.85 - $487.79 $56,616 - $78,046
160 Added 20.15%
954 $413,000
Q3 2021

Nov 05, 2021

BUY
$444.87 - $538.88 $4,003 - $4,849
9 Added 1.15%
794 $385,000
Q2 2021

Aug 02, 2021

SELL
$387.35 - $450.26 $72,821 - $84,648
-188 Reduced 19.32%
785 $353,000
Q4 2020

Feb 03, 2021

BUY
$246.9 - $321.87 $2,222 - $2,896
9 Added 0.93%
973 $309,000
Q3 2020

Nov 12, 2020

BUY
$232.22 - $282.96 $13,468 - $16,411
58 Added 6.4%
964 $239,000
Q2 2020

Aug 06, 2020

BUY
$185.43 - $279.56 $48,026 - $72,406
259 Added 40.03%
906 $239,000
Q1 2020

May 13, 2020

SELL
$161.17 - $221.51 $2,901 - $3,987
-18 Reduced 2.71%
647 $123,000
Q4 2019

Feb 07, 2020

SELL
$189.68 - $222.09 $31,676 - $37,089
-167 Reduced 20.07%
665 $146,000
Q3 2019

Nov 01, 2019

BUY
$183.56 - $216.72 $26,065 - $30,774
142 Added 20.58%
832 $163,000
Q2 2019

Aug 08, 2019

BUY
$188.72 - $215.43 $104,739 - $119,563
555 Added 411.11%
690 $144,000
Q3 2018

Nov 06, 2018

BUY
$147.44 - $204.11 $19,904 - $27,554
135 New
135 $28,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $3.07B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Srs Capital Advisors, Inc. Portfolio

Follow Srs Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.